Two Chimeric Receptors of Epidermal Growth Factor Receptor and c-Ros That Differ in Their Transmembrane Domains Have Opposite Effects on Cell Growth
Open Access
- 1 April 1996
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 16 (4) , 1509-1518
- https://doi.org/10.1128/mcb.16.4.1509
Abstract
Two chimeric receptors, ER1 and ER2, were constructed. ER1 contains the extracellular and transmembrane (TM) domains derived from epidermal growth factor receptor and the cytoplasmic domain from c-Ros; ER2 is identical to ER1 except that its TM domain is derived from c-Ros. Both chimeras can be activated by epidermal growth factor and are capable of activating or phosphorylating an array of cellular signaling proteins. Both chimeras promote colony formation in soft agar with about equal efficiency. Surprisingly, ER1 inhibits while ER2 stimulates cell growth on monolayer culture. Cell cycle analysis revealed that all phases, in particular the S and G2/M phases, of the cell cycle in ER1 cells were elongated whereas G1 phase of ER2 cells was shortened threefold. Comparison of signaling pathways mediated by the two chimeras revealed several differences. Several early signaling proteins are activated or phosphorylated to a higher extent in ER1 than in ER2 cells in response to epidermal growth factor. ER1 is less efficiently internalized and remains tyrosine phosphorylated for a longer time than ER2. However, phosphorylation of the 66-kDa She protein, activation of mitogen activated protein kinase, and induction of c-fos and c-jun occur either to a lesser extent or for a shorter time in ER1 cells. Cellular protein phosphorylation patterns are also different in ER1 and ER2 cells. In particular, a 190-kDa Shc-associated protein is tyrosine phosphorylated in ER2 but not in ER1 cells. Our results indicate that the TM domains have a profound effect on the signal transduction and biological activity of those chimeric receptors. The results also imply that sustained stimulation of ER1 due to its retarded internalization apparently triggers an inhibitory response that dominantly counteracts the receptor-mediated mitogenic signals. These two chimeras, expressed at similar levels in the same cell type but having opposite effects on cell growth, provide an ideal system to study the mechanism by which a protein tyrosine kinase inhibits cell growth.Keywords
This publication has 45 references indexed in Scilit:
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- G1 phase progression: Cycling on cueCell, 1994
- PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiationCurrent Biology, 1994
- EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptorCurrent Biology, 1994
- Chimeric NGF-EGF Receptors Define Domains Responsible for Neuronal DifferentiationScience, 1991
- Signal transduction by receptors with tyrosine kinase activityPublished by Elsevier ,1990
- Two independent mechanisms for escaping epidermal growth factor-mediated growth inhibition in epidermal growth factor receptor-hyperproducing human tumor cells.The Journal of cell biology, 1988
- A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptorNature, 1986
- Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucoseCell, 1986
- Analysis of morphology and receptor metabolism in clonal variant A431 cells with differing growth responses to epidermal growth factorJournal of Cellular Physiology, 1983